Pfizer Inc. (PFE) said it is in talks to buy Wyeth (WYE).  WSJ reports that they have been talking for months now and are not close to a deal yet:

“The two sides have been in discussions for months and a deal isn’t imminent, the people said. Given recent market volatility and overall economic uncertainty, the talks are especially fragile and could collapse, the people warned.”

So, we don’t have a target price yet, but we’ll put this one on our radar.  Today, WYE stock is already up $3/sh to $41.89, or a 7+% jump.